|
Volumn 42, Issue 6, 2000, Pages 349-350
|
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge
c a a b c c c
c
NONE
|
Author keywords
Established allergic contact dermatitis; Nickel; SDZ ASM 981; Treatment
|
Indexed keywords
ALLERGEN;
BETAMETHASONE VALERATE;
CYCLOSPORIN A;
DRUG VEHICLE;
LACTAM DERIVATIVE;
NICKEL SULFATE;
PIMECROLIMUS;
PLACEBO;
ARTICLE;
CLINICAL TRIAL;
CONTACT DERMATITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREAM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG TOLERABILITY;
HUMAN;
HUMAN EXPERIMENT;
MULTICENTER STUDY;
NORMAL HUMAN;
PROVOCATION TEST;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOM;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ALLERGENS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DERMATITIS, ALLERGIC CONTACT;
DERMATOLOGIC AGENTS;
HUMANS;
NICKEL;
OINTMENTS;
PATCH TESTS;
SKIN;
TACROLIMUS;
|
EID: 0034110810
PISSN: 01051873
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0536.2000.042006349.x Document Type: Article |
Times cited : (75)
|
References (6)
|